First-Quarter 2009 Business Review: Sales Growth in Line with Objectives

23 April, 2009

bioMérieux, a global leader in the field of in vitro diagnostics, released its quarterly business review through March 31, 2009.

As of March 31, 2009, net sales amounted to €286 million, up 6.4% at constant exchange rates and scope of consolidation (on a like-for-like basis) versus the first quarter of 2008. Factoring in sales related to business development agreements, the increase was 10.6% at constant exchange rates.

Up 6.4% - At constant exchange rates and scope of consolidation.
Up 10.6% - At constant exchange rates, including business development agreements.

Download the Complete Press Release:

Download
Pioneering Diagnostics